Pfizer and Allergan wend toward a $150B merger, reports say

Tracy Staton

and are coming down to the wire on a that would be the biggest pharma deal ever. The all-stock transaction would be worth up to $ 150 billion, at a price of $ 370 to $ 380 per share, according to media , though analysts have estimated a per-share price of up to $ 400.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS